I was a senior scientist at the Sanger Institute, interested in infectious diseases of global health relevance and international health management.
I was involved in several research projects dealing with host-pathogen interactions, diganostic test development and genomics of various pathogens such as Chlamydia trachomatis, Vibrio cholerae and Mycobacterium tuberculosis.
I have experience in immunology and microbiology of mycobacterial diseases.
Concern regarding the alleged spread of hypervirulent lymphogranuloma venereum Chlamydia trachomatis strain in Europe.
Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin 2017;22;15
Mycobacterium ulcerans Mouse Model Refinement for Pre-Clinical Profiling of Vaccine Candidates.
PloS one 2016;11;11;e0167059
Nature reviews. Microbiology 2016;14;5;271
Vaccination with the Surface Proteins MUL_2232 and MUL_3720 of Mycobacterium ulcerans Induces Antibodies but Fails to Provide Protection against Buruli Ulcer.
PLoS neglected tropical diseases 2016;10;2;e0004431
Herpes simplex type 2 virus deleted in glycoprotein D protects against vaginal, skin and neural disease.
Serological evaluation of Mycobacterium ulcerans antigens identified by comparative genomics.
PLoS neglected tropical diseases 2010;4;11;e872
Auto-reconstitution of the T-cell compartment by radioresistant hematopoietic cells following lethal irradiation and bone marrow transplantation.
Experimental hematology 2010;38;3;222-232.e2
TCR-beta chains derived from peripheral gammadelta T cells can take part in alphabeta T-cell development.
European journal of immunology 2008;38;12;3520-9
Regulatory T cells control autoimmunity following syngeneic bone marrow transplantation.
European journal of immunology 2006;36;9;2324-35
Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.
The Journal of clinical investigation 2003;112;9;1437-43